You can:
Name | Gastric inhibitory polypeptide receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GIPR |
Synonym | GIP-R GIP receptor Glucose-dependent insulinotropic polypeptide receptor Gippr |
Disease | Type 2 diabetes |
Length | 466 |
Amino acid sequence | MTTSPILQLLLRLSLCGLLLQRAETGSKGQTAGELYQRWERYRRECQETLAAAEPPSGLACNGSFDMYVCWDYAAPNATARASCPWYLPWHHHVAAGFVLRQCGSDGQWGLWRDHTQCENPEKNEAFLDQRLILERLQVMYTVGYSLSLATLLLALLILSLFRRLHCTRNYIHINLFTSFMLRAAAILSRDRLLPRPGPYLGDQALALWNQALAACRTAQIVTQYCVGANYTWLLVEGVYLHSLLVLVGGSEEGHFRYYLLLGWGAPALFVIPWVIVRYLYENTQCWERNEVKAIWWIIRTPILMTILINFLIFIRILGILLSKLRTRQMRCRDYRLRLARSTLTLVPLLGVHEVVFAPVTEEQARGALRFAKLGFEIFLSSFQGFLVSVLYCFINKEVQSEIRRGWHHCRLRRSLGEEQRQLPERAFRALPSGSGPGEVPTSRGLSSGTLPGPGNEASRELESYC |
UniProt | P48546 |
Protein Data Bank | N/A |
GPCR-HGmod model | P48546 |
3D structure model | This predicted structure model is from GPCR-EXP P48546. |
BioLiP | N/A |
Therapeutic Target Database | T41750 |
ChEMBL | CHEMBL4383 |
IUPHAR | 248 |
DrugBank | N/A |
Name | CHEMBL2159342 |
---|---|
Molecular formula | C34H31Cl2N3O3 |
IUPAC name | 3-[[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-propan-2-ylnaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid |
Molecular weight | 600.54 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 2 |
XlogP | 8.0 |
Synonyms | BDBM50393786 |
Inchi Key | HHKKVYXTKFAECF-NRFANRHFSA-N |
Inchi ID | InChI=1S/C34H31Cl2N3O3/c1-20(2)24-8-9-26-15-27(11-10-25(26)14-24)32-19-31(28-16-29(35)18-30(36)17-28)38-39(32)21(3)22-4-6-23(7-5-22)34(42)37-13-12-33(40)41/h4-11,14-21H,12-13H2,1-3H3,(H,37,42)(H,40,41)/t21-/m0/s1 |
PubChem CID | 60170857 |
ChEMBL | CHEMBL2159342 |
IUPHAR | N/A |
BindingDB | 50393786 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand is heavier than 500 daltons. This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 431.0 nM | PMID22708876 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218